About Index Trending news
Lists
Pricing
Epic Sciences

Epic Sciences

Epic Sciences

Developing new diagnostic blood tests that can identify and characterize circulating tumor cells to improve cancer detection and to personalize medicine.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital (Series D)
$40,000,000
Debt financing
$15,000,000
Employees

Unknown size

Locations
HQ
Headquarters
Xconomy

Epic Sciences Advances Diagnostic for Late-Stage Prostate Cancer

Health Science Funding
$40,000,000 Venture capital (Series D)
PE Hub

Epic Sciences takes in $40 mln Series D

Funding Messaging